Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

BACKGROUND & AIMS: We determined the optimal HCV treatment prioritization strategy for interferon-free (IFN-free) HCV direct-acting antivirals (DAAs) by disease stage and risk status incorporating treatment of people who inject drugs (PWID). METHODS: A dynamic HCV transmission and progression mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Natasha K., Vickerman, Peter, Dore, Gregory J., Grebely, Jason, Miners, Alec, Cairns, John, Foster, Graham R., Hutchinson, Sharon J., Goldberg, David J., Martin, Thomas C.S., Ramsay, Mary, Hickman, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914770/
https://www.ncbi.nlm.nih.gov/pubmed/26867489
http://dx.doi.org/10.1016/j.jhep.2016.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914770/
https://www.ncbi.nlm.nih.gov/pubmed/26867489
http://dx.doi.org/10.1016/j.jhep.2016.02.007

Ejemplares similares